ArticleFrontiers in medicine2026

Efavirenz treatment improves retinal vaso-obliteration and pathological neovascularization in a mouse model of retinopathy of prematurity.

Briah Bailey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.